FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
Go back to FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval| (NASDAQ: NRXP) | Delayed: 3.29 -0.03 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.32 | 52 Week High | $ | |||
| Open | $3.37 | 52 Week Low | $ | |||
| Day High | $3.39 | P/E | N/A | |||
| Day Low | $3.29 | EPS | $ | |||
| Volume | 379,982 | |||||
